PERSPECTA

News from every angle

← Back to headlines

Soleno Therapeutics Investors Face Securities Fraud Class Action Deadline

Investors in Soleno Therapeutics, Inc. (SLNO) are facing a May 5, 2026, deadline to participate in a securities fraud class action lawsuit.

15 Mar, 19:19 — 15 Mar, 19:19
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh21d ago

Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail

Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit  The Globe and Mail

Read full article →

Related Stories

Philippine Lawmaker Proposes Targeted Energy Crisis Response Bill

just now

Philippine Aviation Authority Explores Sustainable Aviation Fuel Adoption

just now

Philippine President Considers Fuel Excise Tax Suspension

just now

Ferry Fares Rise on Batangas–Occidental Mindoro Route

just now